Your browser doesn't support javascript.
loading
Efficacy and safety of angiogenesis inhibitors plus immune checkpoint inhibitors in advanced soft tissue sarcoma: a real-world, single-center study.
Liu, Zengjun; Xu, Jing; Liu, Mengyao; Hu, Wenyu; Xu, Ni; Zhu, Dongyuan.
Afiliação
  • Liu Z; Rare Tumors Department, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong, China.
  • Xu J; Rare Tumors Department, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong, China.
  • Liu M; Rare Tumors Department, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong, China.
  • Hu W; Rare Tumors Department, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong, China.
  • Xu N; Rare Tumors Department, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong, China.
  • Zhu D; Rare Tumors Department, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong, China. 405683898@qq.com.
Sci Rep ; 13(1): 3385, 2023 02 28.
Article em En | MEDLINE | ID: mdl-36854710

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_arterial_hypertension / 6_other_malignant_neoplasms / 6_thyroid_cancer Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Inibidores da Angiogênese / Inibidores de Checkpoint Imunológico Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_arterial_hypertension / 6_other_malignant_neoplasms / 6_thyroid_cancer Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Inibidores da Angiogênese / Inibidores de Checkpoint Imunológico Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
...